Orphazyme's total assets for Q2 2026 were kr20.11M, an increase of 2.91% from the previous quarter. OZYMF total liabilities were kr702.00K for the fiscal quarter, a -38.90% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.